Elsevier

Annals of Oncology

Volume 25, Issue 8, August 2014, Pages 1462-1474
Annals of Oncology

special articles
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

https://doi.org/10.1093/annonc/mdu089Get rights and content
Under an Elsevier user license
open archive

ABSTRACT

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11–12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on early-stage disease.

Key words

ESMO
consensus
lung cancer
non-small-cell lung cancer
early disease

Cited by (0)

See appendix for Panel Members.